Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seprify has developed a platform for producing high-performance cellulose-based materials that serve as sustainable alternatives to traditional industrial ingredients like titanium dioxide. Their flagship product is a cellulose white pigment suitable for use in food, pharmaceuticals, cosmetics, paints, inks, and coatings. The company has completed successful pilot production and is expanding into new applications such as SPF boosting agents and electronic materials. Life cycle assessments indicate significant potential CO2 savings at scale. The company is not developing drugs but provides enabling technologies for safer consumer goods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seprify.